marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Aclaris Therapeutics Financial Ratios 2011-2024 | ACRS
Annual Financial Ratios Aclaris Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.9 | -9.6 | -9.1 | -5.4 | -0.3 | -1.7 | -9.3 | -11.6 | -6.6 | - | - | - | - |
P/S |
2.7 | 28.0 | 122.0 | 42.5 | 12.9 | 22.9 | 376.9 | - | - | - | - | - | - |
EPS |
-1.3 | -1.3 | -1.6 | -1.2 | -3.9 | -4.0 | -2.4 | -2.2 | -3.8 | -6.2 | -6.5 | - | - |
EV (Enterprise Value) |
84.1 M | 844 M | 851 M | 286 M | 47 M | 234 M | 632 M | 536 M | 127 M | 27.4 M | 13.8 M | - | - |
EBITDA per Share |
-1.38 | -1.37 | -1.57 | -1.17 | -2.08 | -4.01 | -2.56 | -2.26 | -3.37 | - | - | - | - |
EV/EBITDA |
-9.2 | -17.6 | -0.2 | -1.5 | -8.5 | -10.9 | -6.1 | - | - | - | - | ||
PEG |
0.07 | 3.44 | -3.75 | 0.49 | -0.1 | 0.03 | 1.1 | -0.29 | 0.02 | - | - | - | - |
P/B |
0.5 | 4.2 | 4.2 | 7.3 | 0.8 | 1.1 | 2.8 | 3.3 | 1.5 | - | - | - | - |
P/CF |
-1.1 | -12.3 | -15.8 | -7.1 | -0.6 | -2.3 | -11.3 | -16.1 | -6.5 | - | - | - | - |
ROE % |
-56.29 | -43.98 | -46.04 | -135.50 | -230.80 | -61.70 | -30.42 | -28.37 | -22.23 | - | - | - | - |
ROA % |
-44.82 | -34.14 | -36.17 | -72.07 | -164.15 | -48.17 | -28.14 | -27.30 | -21.86 | - | - | - | - |
ROCE % |
-61.94 | -45.47 | -45.47 | -135.22 | -122.00 | -53.95 | -31.39 | -28.59 | -22.34 | - | - | - | - |
Current Ratio |
4.9 | 4.5 | 4.7 | 2.1 | 3.7 | 6.6 | 15.7 | 22.3 | 55.6 | - | - | - | - |
DSO |
4.6 | 6.8 | 37.7 | 41.6 | 60.8 | 175.8 | 104.3 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | 42.1 | - | - | - | - | - | - | - |
DPO |
1025.2 | 922.5 | 590.1 | 539.4 | 892.7 | 786.2 | 2365.4 | - | - | - | - | - | - |
Operating Cycle |
4.6 | 6.8 | 37.7 | 41.6 | 60.8 | 218.0 | 104.3 | - | - | - | - | - | - |
Cash Conversion Cycle |
-1020.6 | -915.7 | -552.4 | -497.8 | -831.9 | -568.2 | -2261.1 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Aclaris Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.11 | -0.15 | -0.24 | - | -0.41 | -0.42 | -0.42 | - | -0.3 | -0.31 | -0.31 | - | -0.35 | -0.34 | -0.57 | - | -0.25 | -0.28 | -0.37 | - | -1.34 | -1.21 | -0.91 | -0.99 | -1.06 | -1.01 | -0.98 | -0.74 | -0.63 | -0.56 | -0.48 | -0.49 | -0.5 | -0.62 | -0.65 | -0.28 | -5.12 | -1.52 | -1.61 | -1.76 | -1.75 | -1.61 | -0.95 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.14 | -0.18 | -0.26 | - | -0.44 | -0.45 | -0.44 | - | -0.31 | -0.32 | -0.3 | - | -0.32 | -0.33 | -0.56 | - | -0.2 | -0.24 | -0.36 | - | -0.41 | -0.95 | -0.6 | - | -0.66 | -1.02 | -0.99 | - | -0.64 | -0.57 | -0.49 | - | -0.5 | -0.63 | -0.65 | - | -4.66 | -1.19 | -1.29 | - | -1.48 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-44.68 | -57.57 | -65.81 | -51.09 | -60.17 | -50.53 | -42.79 | -28.21 | -37.98 | -38.66 | -37.72 | -43.14 | -71.45 | -89.99 | -113.03 | -100.51 | -179.64 | -230.45 | -270.99 | -204.20 | -222.12 | -158.21 | -101.38 | -61.70 | -53.96 | -46.82 | -38.90 | -30.42 | -27.01 | -25.24 | -26.25 | -28.37 | -26.69 | -31.87 | -27.08 | -22.23 | -4.62 | 19.68 | 22.48 | 25.31 | 12.80 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-34.11 | -43.35 | -49.08 | -38.21 | -45.66 | -39.72 | -35.46 | -24.04 | -32.07 | -24.34 | -30.65 | -32.15 | -47.20 | -54.24 | -64.32 | -53.46 | -109.74 | -150.96 | -185.31 | -145.23 | -159.22 | -114.83 | -75.42 | -48.17 | -43.60 | -39.19 | -33.95 | -28.14 | -25.24 | -23.84 | -25.06 | -27.30 | -25.80 | -31.03 | -26.47 | -21.86 | -31.79 | -35.78 | -33.02 | -30.24 | -15.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | - | - | -9.50 | -18.99 | -27.90 | -28.89 | -38.26 | -38.14 | -36.93 | -42.48 | -70.27 | -88.70 | -111.23 | -99.21 | -131.91 | -136.82 | -168.96 | -133.76 | -143.68 | -120.90 | -73.40 | -39.17 | -47.50 | -45.90 | -37.82 | -20.84 | -27.21 | -25.25 | -26.11 | -21.75 | -33.25 | -38.38 | -33.54 | -17.15 | -4.32 | 20.00 | 22.81 | 12.83 | 12.83 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.5 | 5.9 | 5.4 | 4.9 | 3.5 | 4.2 | 4.3 | 4.5 | 5.6 | - | 4.9 | 4.7 | 5.6 | 5.3 | 3.3 | 2.1 | 2.1 | 2.1 | 2.1 | 3.5 | 3.5 | 3.5 | 3.5 | 4.6 | 4.6 | 4.6 | 4.6 | 13.3 | 13.3 | 13.3 | 13.3 | 26.7 | 26.7 | 26.7 | 26.7 | 60.5 | 60.5 | 60.5 | 60.5 | 11.9 | 11.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
7.0 | 11.5 | 12.8 | - | 3.8 | 27.3 | 21.1 | - | 1.4 | 18.9 | 39.4 | - | 48.1 | 43.9 | 40.8 | - | 48.6 | 34.4 | 47.9 | - | 65.3 | 72.5 | 45.8 | 14.0 | 221.3 | 120.7 | 218.0 | 43.9 | 64.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.7 | 47.8 | 62.3 | - | 67.7 | 61.1 | 37.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1041.6 | 1321.9 | 1110.3 | - | 1133.8 | 858.9 | 1047.0 | - | 379.0 | 346.9 | 715.2 | - | 490.2 | 416.7 | 476.2 | - | 403.2 | 345.2 | 545.5 | - | 1095.5 | 910.4 | 816.2 | - | 1261.8 | 1140.0 | 1065.2 | - | 1575.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
7.0 | 11.5 | 12.8 | - | 3.8 | 27.3 | 21.1 | - | 1.4 | 18.9 | 39.4 | - | 48.1 | 43.9 | 40.8 | - | 48.6 | 34.4 | 47.9 | - | 86.0 | 120.3 | 108.0 | 14.0 | 289.0 | 181.8 | 255.3 | 43.9 | 64.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-1034.6 | -1310.4 | -1097.6 | - | -1130.0 | -831.6 | -1025.8 | - | -377.6 | -328.0 | -675.8 | - | -442.1 | -372.8 | -435.4 | - | -354.6 | -310.7 | -497.6 | - | -1009.5 | -790.1 | -708.1 | 14.0 | -972.9 | -958.3 | -809.9 | 43.9 | -1511.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency